Microfluidic interfaces for chronic bidirectional access to the brain
Two-photon polymerization (TPP) is an additive manufacturing technique with micron-scale resolution that is rapidly gaining ground for a range of biomedical applications. TPP is particularly attractive for the creation of microscopic three-dimensional structures in biocompatible and noncytotoxic res...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Marcigaglia, Simone De Plus, Robin Vandendriessche, Charysse Schiltz, Eleonore Cuypers, Marie-Lynn Cools, Jordi Hoffman, Luis D Vandenbroucke, Roosmarijn Dewilde, Maarten Haesler, Sebastian |
description | Two-photon polymerization (TPP) is an additive manufacturing technique with micron-scale resolution that is rapidly gaining ground for a range of biomedical applications. TPP is particularly attractive for the creation of microscopic three-dimensional structures in biocompatible and noncytotoxic resins. Here, TPP is used to develop microfluidic interfaces which provide chronic fluidic access to the brain of preclinical research models. These microcatheters can be used for either convection-enhanced delivery (CED) or for the repeated collection of liquid biopsies. In a brain phantom, infusions with the micronozzle result in more localized distribution clouds and lower backflow compared to a control catheter. In mice, the delivery interface enables faster, more precise, and physiologically less disruptive fluid injections. A second microcatheter design enables repeated, longitudinal sampling of cerebrospinal fluid (CSF) over time periods as long as 250 days. Moreover, further in vivo studies demonstrate that the blood-CSF barrier is intact after chronic implantation of the sampling interface and that samples are suitable for downstream molecular analysis for the identification of nucleic acid- or peptide-based biomarkers. Ultimately, the versatility of this fabrication technique implies a great translational potential for simultaneous drug delivery and biomarker tracking in a range of human neurological diseases.
The limited passage of molecules between the blood and the brain poses a major challenge for drug research and therapy. To address this, the authors use ultrahigh resolution additive manufacturing to develop a miniaturized microcatheter platform for faster, more predictable, and physiologically nondisruptive fluid delivery as well as reliable fluid collection, at rates and with long-term stability not reported before. |
format | Article |
fullrecord | <record><control><sourceid>ghent</sourceid><recordid>TN_cdi_ghent_librecat_oai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY</sourcerecordid><originalsourceid>FETCH-ghent_librecat_oai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY3</originalsourceid><addsrcrecordid>eNqtjNEKgjAYhXdRkJTvsBcQnKLptcxCKbqIpG7GXFP_kA222fO3oEfo3HxwPs5ZoSAhZRIleVZuUGjtK_bJM5IXJED0BMLoYV7gCQKDctIMXEiLB22wmIxWvu69NFI40IrPmAvvLXYau0ni3nBQO7Qe-Gxl-OMW0Zpeq2M0TlI5NkPv59wxzYFxIyZ4S7aMX9VLFpOGXNo27W7npj40aUn3tCLFo7un__r5AGCpUz4</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Microfluidic interfaces for chronic bidirectional access to the brain</title><source>Wiley Online Library</source><source>Ghent University Academic Bibliography</source><creator>Marcigaglia, Simone ; De Plus, Robin ; Vandendriessche, Charysse ; Schiltz, Eleonore ; Cuypers, Marie-Lynn ; Cools, Jordi ; Hoffman, Luis D ; Vandenbroucke, Roosmarijn ; Dewilde, Maarten ; Haesler, Sebastian</creator><creatorcontrib>Marcigaglia, Simone ; De Plus, Robin ; Vandendriessche, Charysse ; Schiltz, Eleonore ; Cuypers, Marie-Lynn ; Cools, Jordi ; Hoffman, Luis D ; Vandenbroucke, Roosmarijn ; Dewilde, Maarten ; Haesler, Sebastian</creatorcontrib><description>Two-photon polymerization (TPP) is an additive manufacturing technique with micron-scale resolution that is rapidly gaining ground for a range of biomedical applications. TPP is particularly attractive for the creation of microscopic three-dimensional structures in biocompatible and noncytotoxic resins. Here, TPP is used to develop microfluidic interfaces which provide chronic fluidic access to the brain of preclinical research models. These microcatheters can be used for either convection-enhanced delivery (CED) or for the repeated collection of liquid biopsies. In a brain phantom, infusions with the micronozzle result in more localized distribution clouds and lower backflow compared to a control catheter. In mice, the delivery interface enables faster, more precise, and physiologically less disruptive fluid injections. A second microcatheter design enables repeated, longitudinal sampling of cerebrospinal fluid (CSF) over time periods as long as 250 days. Moreover, further in vivo studies demonstrate that the blood-CSF barrier is intact after chronic implantation of the sampling interface and that samples are suitable for downstream molecular analysis for the identification of nucleic acid- or peptide-based biomarkers. Ultimately, the versatility of this fabrication technique implies a great translational potential for simultaneous drug delivery and biomarker tracking in a range of human neurological diseases.
The limited passage of molecules between the blood and the brain poses a major challenge for drug research and therapy. To address this, the authors use ultrahigh resolution additive manufacturing to develop a miniaturized microcatheter platform for faster, more predictable, and physiologically nondisruptive fluid delivery as well as reliable fluid collection, at rates and with long-term stability not reported before.</description><identifier>ISSN: 2192-2659</identifier><identifier>ISSN: 2192-2640</identifier><language>eng</language><subject>ALZHEIMERS-DISEASE ; Biology and Life Sciences ; BIOMARKERS ; brain disease ; CENTRAL-NERVOUS-SYSTEM ; CEREBROSPINAL-FLUID ; convection-enhanced delivery ; CSF ; INFUSION ; liquid biopsy ; Medicine and Health Sciences ; MOUSE MODEL ; NEUROTROPHIC FACTOR ; TAU</subject><creationdate>2024</creationdate><rights>Creative Commons Attribution-NonCommercial 4.0 International Public License (CC BY-NC 4.0) info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,315,780,784,4024,27860</link.rule.ids></links><search><creatorcontrib>Marcigaglia, Simone</creatorcontrib><creatorcontrib>De Plus, Robin</creatorcontrib><creatorcontrib>Vandendriessche, Charysse</creatorcontrib><creatorcontrib>Schiltz, Eleonore</creatorcontrib><creatorcontrib>Cuypers, Marie-Lynn</creatorcontrib><creatorcontrib>Cools, Jordi</creatorcontrib><creatorcontrib>Hoffman, Luis D</creatorcontrib><creatorcontrib>Vandenbroucke, Roosmarijn</creatorcontrib><creatorcontrib>Dewilde, Maarten</creatorcontrib><creatorcontrib>Haesler, Sebastian</creatorcontrib><title>Microfluidic interfaces for chronic bidirectional access to the brain</title><description>Two-photon polymerization (TPP) is an additive manufacturing technique with micron-scale resolution that is rapidly gaining ground for a range of biomedical applications. TPP is particularly attractive for the creation of microscopic three-dimensional structures in biocompatible and noncytotoxic resins. Here, TPP is used to develop microfluidic interfaces which provide chronic fluidic access to the brain of preclinical research models. These microcatheters can be used for either convection-enhanced delivery (CED) or for the repeated collection of liquid biopsies. In a brain phantom, infusions with the micronozzle result in more localized distribution clouds and lower backflow compared to a control catheter. In mice, the delivery interface enables faster, more precise, and physiologically less disruptive fluid injections. A second microcatheter design enables repeated, longitudinal sampling of cerebrospinal fluid (CSF) over time periods as long as 250 days. Moreover, further in vivo studies demonstrate that the blood-CSF barrier is intact after chronic implantation of the sampling interface and that samples are suitable for downstream molecular analysis for the identification of nucleic acid- or peptide-based biomarkers. Ultimately, the versatility of this fabrication technique implies a great translational potential for simultaneous drug delivery and biomarker tracking in a range of human neurological diseases.
The limited passage of molecules between the blood and the brain poses a major challenge for drug research and therapy. To address this, the authors use ultrahigh resolution additive manufacturing to develop a miniaturized microcatheter platform for faster, more predictable, and physiologically nondisruptive fluid delivery as well as reliable fluid collection, at rates and with long-term stability not reported before.</description><subject>ALZHEIMERS-DISEASE</subject><subject>Biology and Life Sciences</subject><subject>BIOMARKERS</subject><subject>brain disease</subject><subject>CENTRAL-NERVOUS-SYSTEM</subject><subject>CEREBROSPINAL-FLUID</subject><subject>convection-enhanced delivery</subject><subject>CSF</subject><subject>INFUSION</subject><subject>liquid biopsy</subject><subject>Medicine and Health Sciences</subject><subject>MOUSE MODEL</subject><subject>NEUROTROPHIC FACTOR</subject><subject>TAU</subject><issn>2192-2659</issn><issn>2192-2640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ADGLB</sourceid><recordid>eNqtjNEKgjAYhXdRkJTvsBcQnKLptcxCKbqIpG7GXFP_kA222fO3oEfo3HxwPs5ZoSAhZRIleVZuUGjtK_bJM5IXJED0BMLoYV7gCQKDctIMXEiLB22wmIxWvu69NFI40IrPmAvvLXYau0ni3nBQO7Qe-Gxl-OMW0Zpeq2M0TlI5NkPv59wxzYFxIyZ4S7aMX9VLFpOGXNo27W7npj40aUn3tCLFo7un__r5AGCpUz4</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Marcigaglia, Simone</creator><creator>De Plus, Robin</creator><creator>Vandendriessche, Charysse</creator><creator>Schiltz, Eleonore</creator><creator>Cuypers, Marie-Lynn</creator><creator>Cools, Jordi</creator><creator>Hoffman, Luis D</creator><creator>Vandenbroucke, Roosmarijn</creator><creator>Dewilde, Maarten</creator><creator>Haesler, Sebastian</creator><scope>ADGLB</scope></search><sort><creationdate>2024</creationdate><title>Microfluidic interfaces for chronic bidirectional access to the brain</title><author>Marcigaglia, Simone ; De Plus, Robin ; Vandendriessche, Charysse ; Schiltz, Eleonore ; Cuypers, Marie-Lynn ; Cools, Jordi ; Hoffman, Luis D ; Vandenbroucke, Roosmarijn ; Dewilde, Maarten ; Haesler, Sebastian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-ghent_librecat_oai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>ALZHEIMERS-DISEASE</topic><topic>Biology and Life Sciences</topic><topic>BIOMARKERS</topic><topic>brain disease</topic><topic>CENTRAL-NERVOUS-SYSTEM</topic><topic>CEREBROSPINAL-FLUID</topic><topic>convection-enhanced delivery</topic><topic>CSF</topic><topic>INFUSION</topic><topic>liquid biopsy</topic><topic>Medicine and Health Sciences</topic><topic>MOUSE MODEL</topic><topic>NEUROTROPHIC FACTOR</topic><topic>TAU</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marcigaglia, Simone</creatorcontrib><creatorcontrib>De Plus, Robin</creatorcontrib><creatorcontrib>Vandendriessche, Charysse</creatorcontrib><creatorcontrib>Schiltz, Eleonore</creatorcontrib><creatorcontrib>Cuypers, Marie-Lynn</creatorcontrib><creatorcontrib>Cools, Jordi</creatorcontrib><creatorcontrib>Hoffman, Luis D</creatorcontrib><creatorcontrib>Vandenbroucke, Roosmarijn</creatorcontrib><creatorcontrib>Dewilde, Maarten</creatorcontrib><creatorcontrib>Haesler, Sebastian</creatorcontrib><collection>Ghent University Academic Bibliography</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marcigaglia, Simone</au><au>De Plus, Robin</au><au>Vandendriessche, Charysse</au><au>Schiltz, Eleonore</au><au>Cuypers, Marie-Lynn</au><au>Cools, Jordi</au><au>Hoffman, Luis D</au><au>Vandenbroucke, Roosmarijn</au><au>Dewilde, Maarten</au><au>Haesler, Sebastian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microfluidic interfaces for chronic bidirectional access to the brain</atitle><date>2024</date><risdate>2024</risdate><issn>2192-2659</issn><issn>2192-2640</issn><abstract>Two-photon polymerization (TPP) is an additive manufacturing technique with micron-scale resolution that is rapidly gaining ground for a range of biomedical applications. TPP is particularly attractive for the creation of microscopic three-dimensional structures in biocompatible and noncytotoxic resins. Here, TPP is used to develop microfluidic interfaces which provide chronic fluidic access to the brain of preclinical research models. These microcatheters can be used for either convection-enhanced delivery (CED) or for the repeated collection of liquid biopsies. In a brain phantom, infusions with the micronozzle result in more localized distribution clouds and lower backflow compared to a control catheter. In mice, the delivery interface enables faster, more precise, and physiologically less disruptive fluid injections. A second microcatheter design enables repeated, longitudinal sampling of cerebrospinal fluid (CSF) over time periods as long as 250 days. Moreover, further in vivo studies demonstrate that the blood-CSF barrier is intact after chronic implantation of the sampling interface and that samples are suitable for downstream molecular analysis for the identification of nucleic acid- or peptide-based biomarkers. Ultimately, the versatility of this fabrication technique implies a great translational potential for simultaneous drug delivery and biomarker tracking in a range of human neurological diseases.
The limited passage of molecules between the blood and the brain poses a major challenge for drug research and therapy. To address this, the authors use ultrahigh resolution additive manufacturing to develop a miniaturized microcatheter platform for faster, more predictable, and physiologically nondisruptive fluid delivery as well as reliable fluid collection, at rates and with long-term stability not reported before.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2192-2659 |
ispartof | |
issn | 2192-2659 2192-2640 |
language | eng |
recordid | cdi_ghent_librecat_oai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY |
source | Wiley Online Library; Ghent University Academic Bibliography |
subjects | ALZHEIMERS-DISEASE Biology and Life Sciences BIOMARKERS brain disease CENTRAL-NERVOUS-SYSTEM CEREBROSPINAL-FLUID convection-enhanced delivery CSF INFUSION liquid biopsy Medicine and Health Sciences MOUSE MODEL NEUROTROPHIC FACTOR TAU |
title | Microfluidic interfaces for chronic bidirectional access to the brain |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T00%3A56%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-ghent&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microfluidic%20interfaces%20for%20chronic%20bidirectional%20access%20to%20the%20brain&rft.au=Marcigaglia,%20Simone&rft.date=2024&rft.issn=2192-2659&rft_id=info:doi/&rft_dat=%3Cghent%3Eoai_archive_ugent_be_01J1PKK3WVNJFGJ39E7EC18ZWY%3C/ghent%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |